Research & Development Database
Introduction
You are very welcome to use our R&D projects database on the following conditions.
Below, you could read statistical data on the projects numbers, which are additionally divided into biotech-related sectors to give you an idea about the content.
Moreover, in the next tab we provide you with an example of a fictive R&D project, to present the way the data are organized in a single record. The example will be replaced by the exact database content upon subscription.
The database user has also on opportunity of collecting chosen project descriptions in a personal basket, which keeps content for the whole subscription period.
The database is currently intensively developing, therefore, the 3-month subscription is more profitable option. Statistical data on this site will adjust to the constantly extending database.
In the next step, the database projects will be further described and their commercialization potential will be gradually evaluated, increasing value of the provided data. Please note that by then, the initial not yet evaluated projects are based mainly on the information from their leaders.
The aim is to gather remarkable numbers of projects coming from laboratories of Central Europe, in order to show the biotech-related potential of the region.
Subscription
It is necessary to register on CEBiotech.com to view this database.
If you have registered your account already, you may subscribe for the R&D projects database access on your account page.
Statistics
All projects: 32
divided into
|
sectors: Bioproducts Bioremediation Diagnostics Immunity boosting Lab equipment & reagents Nutrition Pharmaceuticals Plant protection Regenerative medicine |
5 4 9 1 1 2 8 1 1 |
countries of origin: Hungary Poland |
1 31 |
Database author
Bio-Tech Consulting exists in the consulting market of pharmacy and biotechnology for over 10 years now. Our mission is promoting introduction of modern biotechnologies into the Bioeconomy sector. Thus, we intend to become the most important partner for scientists and businessmen in the process of fast implementation of scientific achievements into the business practice, as well as creating company's development potential on the basis of knowledge and its power to yield economical successes.
We stimulate, organize and coordinate cooperation of capital investors, innovative companies and scientists in the Bioeconomy sector. We create databases and advanced channels of scientific and business information flow for this environment. We also assess commercialization potential of scientific projects and provide professional trainings.
Contact
In case of any inquiries or special requests you are very welcome to contact us.
We especially appreciate your feedback on the service in order to adjust it to your needs.
Magdalena Zychlinska Ph.D.
magdalena.zychlinska@biotechconsulting.pl
phone +48 42 299 6085, mobile +48 600 812 332
EXAMPLE - FICTIVE R&D PROJECT: Quick screen for tumor markers
| project leader |
| ZYCHLINSKA Magdalena, PhD - Database manager |
| magdalena.zychlinska@biotechconsulting.pl |
| phone: +48 42 299 6085, +48 600 812 332 |
| Poland |
| 90-229 Lodz, Kaminskiego 23 |
| from |
| company |
| Bio-Tech Consulting Ltd |
| product/technology |
| CANCER DETECTION TEST |
| The diagnostic array allows for an immediate determination of increased values of tumor markers. Special features Diagnosis of already advanced tumors frequently results in high mortality rates. Detection via tumor markers enables early prognosis and so, better survival. The test mechanism is based on immunoassay and is provided in form of small detector reading sample diagnostic strips. Chip format encloses a chosen set of most important protein markers (BRCA, PSA, CA125) permitting broad screen for increased tumor risk. Suggested application The device can be easily operated by a doctor at private medical practice, in hospital or health centre. The results are given to patients during the same visit. Patients with increased cancer risk (e.g. strong family history) could be easily checked for the present risk status. |
|
IPR status: Patent |
| project stage: In vivo studies |




